Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anaphylaxis and hypotension after administration of peginesatide.

Literature DB >> 24849101

Anaphylaxis and hypotension after administration of peginesatide.

Charles L Bennett¹, Sony Jacob, Jeffrey Hymes, Len A Usvyat, Franklin W Maddux.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2014 PMID： 24849101 PMCID： PMC4200528 DOI： 10.1056/NEJMc1400883

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

4 in total

Review 1. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?

Authors: Iain C Macdougall
Journal: Curr Med Res Opin Date: 2010-02 Impact factor: 2.580

2. Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

Authors: Iain C Macdougall; Robert Provenzano; Amit Sharma; Bruce S Spinowitz; Rebecca J Schmidt; Pablo E Pergola; Raja I Zabaneh; Sandra Tong-Starksen; Martha R Mayo; Hong Tang; Krishna R Polu; Anne-Marie Duliege; Steven Fishbane
Journal: N Engl J Med Date: 2013-01-24 Impact factor: 91.245

3. Peginesatide in patients with anemia undergoing hemodialysis.

Authors: Steven Fishbane; Brigitte Schiller; Francesco Locatelli; Adrian C Covic; Robert Provenzano; Andrzej Wiecek; Nathan W Levin; Mark Kaplan; Iain C Macdougall; Carol Francisco; Martha R Mayo; Krishna R Polu; Anne-Marie Duliege; Anatole Besarab
Journal: N Engl J Med Date: 2013-01-24 Impact factor: 91.245

Review 4. A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR).

Authors: Charles L Bennett; David M Spiegel; Iain C Macdougall; LeAnn Norris; Zaina P Qureshi; Oliver Sartor; Stephen Y Lai; Martin S Tallman; Dennis W Raisch; Sheila Weiss Smith; Samuel Silver; Alanna S Murday; James O Armitage; David Goldsmith
Journal: Semin Thromb Hemost Date: 2012-10-30 Impact factor: 4.180

4 in total

14 in total

1. Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know?

Authors: Charles Lee Bennett; Terhi Hermanson
Journal: Clin J Am Soc Nephrol Date: 2015-09-28 Impact factor: 8.237

Review 2. Regulatory and clinical considerations for biosimilar oncology drugs.

Authors: Charles L Bennett; Brian Chen; Terhi Hermanson; Michael D Wyatt; Richard M Schulz; Peter Georgantopoulos; Samuel Kessler; Dennis W Raisch; Zaina P Qureshi; Z Kevin Lu; Bryan L Love; Virginia Noxon; Laura Bobolts; Melissa Armitage; John Bian; Paul Ray; Richard J Ablin; William J Hrushesky; Iain C Macdougall; Oliver Sartor; James O Armitage
Journal: Lancet Oncol Date: 2014-11-24 Impact factor: 41.316

3. Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.

Authors: Brian Chen; Sumimasa Nagai; James O Armitage; Bartlett Witherspoon; Chadi Nabhan; Ashley C Godwin; Y Tony Yang; Anuhya Kommalapati; Sri Harsha Tella; Carlo DeAngelis; Dennis W Raisch; Oliver Sartor; William J Hrushesky; Paul S Ray; Paul R Yarnold; Bryan L Love; LeAnn B Norris; Kevin Knopf; Laura Bobolts; Joshua Riente; Stefano Luminari; Robert C Kane; Shamia Hoque; Charles L Bennett
Journal: Oncologist Date: 2019-03-06

Review 4. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.

Authors: Emilee R Wilhelm-Leen; Wolfgang C Winkelmayer
Journal: Am J Kidney Dis Date: 2015-01-28 Impact factor: 8.860

Review 5. Anemia: progress in molecular mechanisms and therapies.

Authors: Vijay G Sankaran; Mitchell J Weiss
Journal: Nat Med Date: 2015-03 Impact factor: 53.440

6. A dimeric peptide with erythropoiesis-stimulating activity uniquely affects erythropoietin receptor ligation and cell surface expression.

Authors: Rakesh Verma; Jennifer M Green; Peter J Schatz; Don M Wojchowski
Journal: Exp Hematol Date: 2016-05-09 Impact factor: 3.084